Ayurvedic and Chinese Herbs against Coronaviruses

Area of Science:

• Integrative Medicine
• Phytochemistry
• Virology

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents significant global health and economic challenges.
• The rapid spread and high mutation rate of SARS-CoV-2 highlight the urgent need for effective therapeutic strategies.
• Traditional systems like Ayurveda and Traditional Chinese Medicine (TCM) offer a historical basis for utilizing natural compounds in healthcare.

Purpose of the Study:

• To review the role of specific TCM and Ayurvedic medicinal plants in managing COVID-19 infection.
• To explore the potential of these traditional remedies in enhancing immunity and supporting post-infection recovery.
• To identify phytochemicals from these plants as potential inhibitors of viral mechanisms.

Main Methods:

• Literature review of studies on Ayurvedic and TCM medicinal plants with antiviral properties.
• Analysis of phytochemical constituents and their mechanisms of action against SARS-CoV-2.
• Identification of key plants such as Glycyrrhiza glabra, Curcuma longa, and Zingiber officinale.

Main Results:

• Ayurvedic and TCM herbs can modulate immune responses and inflammation relevant to COVID-19.
• Phytochemicals from these plants show potential in inhibiting viral replication, attachment, and protease activity.
• Specific herbs like licorice, turmeric, and ginger are identified as promising antiviral agents.

Conclusions:

• Medicinal plants from Ayurveda and TCM possess bioactive compounds that can combat COVID-19 infection.
• These natural products may serve as valuable sources for developing novel antiviral therapies and supportive treatments for COVID-19.
• Further research into these phytoconstituents could lead to effective strategies for prevention and rehabilitation.